Periodization Resistance Training on Quality of Life in Females With Hypothyroidism
Nonlinear Versus Linear Periodized Resistance Training on Quality of Life in Females With Hypothyroidism
1 other identifier
interventional
75
1 country
1
Brief Summary
This study will be conducted to compare between the effect of nonlinear and linear periodized training on quality of life in females with hypothyroidism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 27, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedFirst Posted
Study publicly available on registry
January 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2025
CompletedSeptember 12, 2025
September 1, 2025
9 months
December 27, 2024
September 7, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Serum thyroid stimulating hormone (TSH) level
It will be measured by ELISA kits. This kit is an Enzyme Linked Immunosorbent Assay (ELISA). (Precheck bio, inc, @ EIA KIT, USA).
12 weeks
FreeT4 (thyroxine) level
It will be measured by ELISA kits. This kit is an Enzyme Linked Immunosorbent Assay (ELISA). (Precheck bio, inc, @ EIA KIT, USA).
12 weeks
Health related Quality of life questionnaire
The Health related Quality of life will be assessed using short form 12 (SF-12), which uses only 12 questions to measure functional health and well being from the patient's perspective. Scores range from 0 to 100, with higher scores indicating better physical and mental health functioning.
12 weeks
Secondary Outcomes (3)
Triglyceride-glucose (TyG) index
12 weeks
Hand grip strength
12 weeks
9-item Fatigue Severity Scale (FSS)
12 weeks
Study Arms (3)
non linear periodization exercise + medical treatment
EXPERIMENTALIt will consist of 25 females, who will receive non linear periodization exercise in addition to their medical treatment.
linear periodization exercise + medical treatment
EXPERIMENTALIt will consist of 25 females, who will receive linear periodization exercise in addition to their medical treatment.
medical treatment
ACTIVE COMPARATORIt will consist of 25 females, who will receive their medical treatment only.
Interventions
The non-linear periodized resistance training program follows a 12-week schedule with varying intensity levels across three training days per week. The intensity fluctuates between very light (VL), light (L), moderate (M), heavy (H), and very heavy (VH) workouts, distributed strategically throughout the week. Each training day implements different intensity levels, and an active rest day follows any workout session.
The linear periodization exercise program spans 12 weeks with systematically varied training parameters. During weeks 1-2, participants perform 3 sets of 10 repetitions, followed by 3 sets of 8 repetitions in weeks 3-4. The program progresses to 4 sets of 6 repetitions in weeks 5-6, then 3 sets of 6 repetitions during weeks 7-8. The final phases consist of 4 sets of 4 repetitions in weeks 9-10, concluding with 3 sets of 4 repetitions in weeks 11-12. Training loads advance through autoregulatory progression, where participants progress at their individual pace under supervision. While sets and repetitions remain fixed within each phase, load progression is determined by performance in the final set of each exercise, ensuring safe and effective advancement.
The medical treatment will be received for 12 weeks.
Eligibility Criteria
You may qualify if:
- Be controlled hypothyroidism (TSH level within 0.5 - 4.5 mU/L)
- Be ranged from 35 to 45 years
- Female patients
- Body Mass Index 30-34.9 kg/m2 .
- triglyceride-glucose (TyG) index \> 4.5
You may not qualify if:
- history of pulmonary disease
- Patients with uncontrolled coronary or cerebrovascular disease
- Those who underwent musculoskeletal surgery within the previous year
- Recent history of lower and upper limb fracture , hip and shoulder dislocation.
- Cognitive impaired patients
- Patients with history of epilepsy
- Patients who participating in any other exercise program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Suez University
Suez, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Nesreen Gharib Mohamed Elnahas, PhD
Professor, Cairo university
Central Study Contacts
Salma Ibrahim Al Ghitany, PhD
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 27, 2024
First Posted
January 3, 2025
Study Start
January 1, 2025
Primary Completion
October 1, 2025
Study Completion
October 15, 2025
Last Updated
September 12, 2025
Record last verified: 2025-09